Beyond the NPI: Why Pharma Marketers Are Rethinking HCP Targeting in 2026

HealthWise Data's Provider Consumer Intelligence solution connects leverages deterministic NPI linkage to connect HCPs to their consumer profile for a 360-degree view.

Healthcare providers are more than prescribers. So why are you still targeting them like they aren’t?

Pharmaceutical marketers have access to more HCP data than at any point in history — specialty codes, prescribing history, claims data, sales rep interaction logs. And yet, 70% of healthcare providers say pharma companies still don’t fully understand their needs and expectations.

That’s not a data volume problem. That’s a data type problem.

The standard toolkit for HCP targeting was built to answer one question: What does this physician prescribe? It was never designed to answer the question that actually drives engagement: Who is this physician as a person, and how do I reach them in a way that actually resonates?

That blind spot is getting harder to ignore in 2026. As physician access continues to shrink — only 45% of US physicians now make themselves available to pharmaceutical companies — and as addressable channels like connected TV reshape where and how engagement happens, the clinical-only view of the HCP is running out of road.

This post breaks down why the dominant approach to HCP targeting is structurally limited, what a better framework looks like, and how pharmaceutical marketers can close the gap between knowing a provider’s specialty and understanding them as a whole person.

The Three Cracks in Traditional HCP Targeting

1. Clinical-only data misses the human making the decision

Most HCP databases are built from professional sources: NPI records, specialty classifications, prescribing data pulled from claims. These are genuinely useful inputs. But they describe what a provider does at work, not who they are when they leave.

Physicians go home. They watch television, browse the open web, field financial pressures, navigate family dynamics, and live in communities that shape how they see the world — including how they evaluate therapies and engage with clinical information. The personal context that surrounds a provider’s professional life is directly relevant to how they process and respond to brand messaging.

When 80% of HCPs express skepticism about the scientific validity of pharma communications, and roughly half report experiencing content fatigue, it isn’t a creative problem alone. It’s a relevance problem — one rooted in messaging that’s calibrated to a clinical profile instead of a complete person.

2. Fragmented campaigns create fragmented influence

Here’s a structural issue that rarely gets named directly: pharmaceutical brand teams run HCP awareness campaigns. Patient services and DTC teams run consumer campaigns. And the two efforts exist almost entirely in isolation, hoping the message somehow intersects in the exam room.

The data tells a stark story: 70% of HCPs agree that synchronizing HCP and DTC marketing would improve patient care outcomes. Only 13% say they actually see that alignment in practice.

That gap isn’t just an efficiency problem; it’s a missed influence opportunity. When a provider is educated about a therapy at the same time a relevant patient population is being activated, the clinical conversation is primed before it starts. Without a shared data foundation connecting provider identity to patient population intelligence, that coordination is nearly impossible.

3. Verified HCP reach and omnichannel access don’t go together — until now

Marketers trying to reach physicians in the modern media environment face a frustrating binary. Clinical platforms and physician networks offer deterministic, verified HCP audiences — but they’re walled gardens, limiting distribution to in-office or professional environments. DSPs and programmatic channels offer omnichannel scale — but deterministic HCP verification at the person level while also being tied to the consumer profile is basically unavailable.

The result: among pharma marketers already buying CTV advertising, only 6% are reaching HCP-only audiences. More than half — 54% — substitute broad geo-demographic targeting for actual physician verification. And nearly half of pharma marketers (48.4%) admit they’re not applying consistent audience targeting across TV formats and platforms, even as CTV and addressable TV investment grows.

Connected television is now one of the highest-attention media environments available. Verified physicians are watching it at home every night. The tools to bridge those two facts have, until recently, simply not existed.

The “Scrubs Off, Sneakers On” Moment Healthcare Marketing Has Been Missing

When a physician closes the exam room door at the end of the day, they don’t stop being a person with demographics, media habits, financial realities, and community context. They just stop being in a clinical setting.

That transition — from provider to person — is exactly where healthcare marketing has historically gone dark.

The concept of the provider as consumer isn’t just a philosophical reframe. It’s a structural data opportunity. Healthcare providers are present in the same consumer identity graphs as everyone else. They have home addresses. They have household income ranges. They stream TV and scroll social media. They live in neighborhoods with specific SDOH profiles that reflect — and shape — the patient populations they serve.

Connecting a provider’s professional identity to their consumer reality doesn’t dilute the clinical relevance of HCP marketing. It enhances it. When you understand the personal context surrounding clinical decisions, you can build messaging that resonates at the human level, reach providers across channels that weren’t previously available to you, and coordinate that outreach with a patient activation strategy grounded in the same underlying data.

This is the shift that Provider Consumer Intelligence, the professional to personal data linkage solution from HealthWise Data, was built to enable.

What Provider Consumer Intelligence Actually Delivers

HealthWise Data’s Provider Consumer Intelligence solution does something that has historically required stitching together multiple vendors, data sources, and activation partners: it links healthcare provider professional identity directly to consumer identity — at scale, with deterministic accuracy.

The foundation is a deterministic NPI-to-consumer linkage covering 3.4 million matched NPI-PID pairs, validated at 99.7% matching accuracy. Every match connects a Type 1 NPI record to a HealthWise Data consumer identity, turning what is traditionally a reference file into an actionable intelligence layer.

What that unlocks across a matched record is substantial: 

  • Individual demographics including age, gender, income, marital status, household makeup, language, and ethnicity
  • Predictive media consumption habits across 10+ marketing channels from Instagram to connected TV
  • HealthWise Data Messaging Clusters and Digital Clusters for high-speed segmentation and tailored messaging
  • Navigate 360 access for SDOH-enriched insights into the communities providers serve
  • The ability to append any of HealthWise Data’s 1,000+ additional data variables based on specific campaign or analytics objectives.

Professional context travels alongside all of it: specialty code, NPI number, prescriber status, and professional affiliation are included in every matched record, so HCP verification is never sacrificed for consumer depth.

Activation is fully addressable. Matched audiences can be deployed across connected TV, programmatic display, direct mail, and the LiveRamp marketplace — reaching verified physicians at home, across devices, and in media environments that clinical targeting platforms simply cannot access.

And critically, the solution is designed with privacy at its core. All data linkage and activation is HIPAA-compliant, and physician opt-out preferences are respected throughout.

Two Ways to Start — Build a List, or Bring Your Own

One of the most common objections to adopting a new data solution is that marketers have already invested in building their own curated HCP lists. Provider Consumer Intelligence is designed to work both ways.

If you want to build a new audience from scratch: HealthWise Data can query the matched NPI universe directly against your targeting criteria — specialty, geography, prescriber status, demographic profile, SDOH context, media habits — and size and deliver a custom HCP audience built to your specific campaign or analytics goals.

If you already have a curated HCP list: You can bring your file to HealthWise Data for enrichment. The team applies data hygiene, links your NPI records to person-level consumer IDs, and appends up to 1,000+ variables from the HealthWise Data universe to the records you already own. Your specialized list becomes significantly more intelligent, and your investment in building it is preserved rather than replaced.

This flexibility matters because it removes a significant barrier to adoption. You don’t have to start over. You can make what you already have dramatically more powerful.

The Unified Campaign Advantage

The most strategically significant capability of Provider Consumer Intelligence isn’t the depth of any individual data variable. It’s the ability to connect HCP and DTC campaign strategy within a single data framework.

Consider the practical implication: a pharmaceutical brand can now identify oncologists serving high-SDOH patient populations and the predicted patients in those communities who may need immunotherapy — in one unified campaign, drawing from one data partner, with deterministic verification across every channel.

The impact of that coordination is measurable. Unified campaigns leveraging this kind of connected intelligence have delivered a 4.32 return on ad spend across consumer audiences and 6.48 across provider audiences. When the provider education strategy and the patient activation strategy are drawing from the same intelligence layer, the influence compounds in a way that siloed campaigns simply can’t replicate.

With 57% of pharma companies now ranking HCP insight as their top strategic engagement priority, this isn’t a theoretical benefit. It’s the performance gap that the market is actively trying to close.

How This Compares to What’s Already Out There

The HCP data and targeting landscape has matured considerably, which means pharmaceutical marketers have real alternatives to evaluate. It’s worth being direct about where those alternatives fall short.

Clinical-only databases and NPI enrichment tools deliver strong professional depth: specialty, prescribing history, claims data, rep interaction logs. What they don’t deliver is the consumer layer — the demographics, behaviors, media habits, and community context that exist outside the clinical identity. You know what the physician prescribes. You don’t know who they are when they go home.

Physician-focused walled gardens solve for verified reach within professional environments. The constraint is that “professional environment” is the operative limitation — access is bounded to in-office or platform-native placements. Reaching a verified physician on connected television, or across the open programmatic web, or via direct mail to a home address requires data that most of these platforms simply don’t hold.

Broader consumer data platforms can deliver demographic overlays on physician lists, but they typically lack the deterministic NPI-to-person linkage that makes HCP verification reliable. The result is consumer data appended to an imprecise HCP foundation — scale without confidence.

Provider Consumer Intelligence occupies the intersection that none of these options covers: deterministic professional verification plus consumer depth plus fully addressable omnichannel activation, all from a single partner.

Who Should Be Looking at This Now

The primary audience for Provider Consumer Intelligence is pharmaceutical brand marketers and commercial analytics teams at mid-to-large pharma companies who have plateaued on specialty-level HCP segmentation and need a more sophisticated foundation for targeting, messaging, and prescribing behavior prediction.

But the applicability runs broader than pharma. Medical device manufacturers can map provider demographics and behavioral profiles to device adoption patterns and purchase predictions. Payer network development teams can use geographic specialty intelligence and SDOH data to identify network gaps and recruit providers strategically. Clinical trial sponsors and CROs can identify rising-star researchers and early adopters among the matched HCP population. Healthcare agencies managing multi-channel campaigns for any of these clients gain a single data partner that bridges the HCP and consumer brief.

If your current HCP strategy relies primarily on professional-only data sources, and you’re not yet reaching verified providers across CTV and programmatic, you’re already behind where this market is heading.

Build Your Next-Generation HCP Strategy

The opportunity here is straightforward. Healthcare providers don’t stop being people when they walk into the exam room, and they don’t stop being reachable when they walk out. The data infrastructure to engage them as whole people across the channels they actually use, informed by the personal context that actually shapes their decisions, now exists.

HealthWise Data is ready to show you what it looks like applied to your specific goals. The next step can be a Profile Report that reveals hidden patterns in your current HCP universe via Navigate 360, a Match Test where you send us your existing HCP file and we show you what the enriched record looks like, or a Custom Audience Query where we build and size a list from scratch based on your targeting criteria.

Whichever path makes sense for where you are, the conversation starts the same way: with a call.

Book a call with HealthWise Data →

HealthWise Data provides privacy-safe, HIPAA-compliant consumer intelligence for healthcare audiences. Provider Consumer Intelligence links 3.4 million NPI records to the HealthWise Data consumer universe, enabling pharmaceutical, medical device, payer, and clinical trial organizations to understand and reach healthcare providers as complete people.